220996-36-1

Basic information

• Product Name: tert-butyl 4-(4-acetyl-3-hydroxyphenoxy)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-acetyl-3-hydroxyphenoxy)piperidine-1-carboxylate
• CAS NO: 220996-36-1
• Molecular Weight: 335.4
• Mol File: 220996-36-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(4-acetyl-3-hydroxyphenoxy)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-acetyl-3-hydroxyphenoxy)piperidine-1-carboxylate(220996-36-1)
• EPA Substance Registry System: tert-butyl 4-(4-acetyl-3-hydroxyphenoxy)piperidine-1-carboxylate(220996-36-1)

Safety Data

• Hazardous Substances Data: 220996-36-1(Hazardous Substances Data)

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 

Downstream Products

• 220996-37-2 4-(N-tert-butyloxycarbonyl-4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)-acetophenone 
• 170930-04-8 methyl 2-methoxy-4-(1-Boc-4-piperidyloxy)-phenylacetate 
• 162045-86-5 4-(N-tert-butyloxycarbonyl-4-piperidinyloxy)-2-methoxyphenylacetic acid 
• 220996-38-3 methyl 4-(N-tert-butyloxycarbonyl-4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)phenyl-acetate 
• 220996-39-4 4-(N-tert-butyloxycarbonyl-4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)phenylacetic acid 
• 196794-09-9 1-(1-{[2-methoxy-4-(piperidin-4-yloxy)-phenyl]-acetyl}-piperidin-4-yl)-1,4-dihydro-benzo[d][1,3]oxazin-2-one 
• 162045-87-6 4-(3-methoxy-4-{2-oxo-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1-yl)-piperidin-1-yl]-ethyl}-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester 
• 221285-11-6 1-(1-(4-(4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)phenylacetyl)-piperidin-4-yl)-4H-3,1-benzoxazin-2(1H)-one 
• 221284-06-6 1-(1-(4-(1-acetyl-4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)-phenyl-acetyl)piperidin-4-yl)-4H-3,1-benzoxazin-2(1H)-one 
• 221284-02-2 1-(1-(4-(1-tert-butyloxycarbonyl-4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)phenylacetyl)piperidin-4-yl)-4H-3,1-benzoxazin-2(1H)-one 
• 1369358-02-0 tert-butyl 4-(4-acetyl-3-(methoxymethoxy)phenoxy)piperidine-1-carboxylate 
• 1369358-11-1 2-(5-((1-(methylsulfonyl)piperidin-4-yl)oxy)-2-(2-oxo-2-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)piperidin-1-yl)ethyl)phenoxy)ethyl 4-methylbenzenesulfonate 
• 1369357-99-2 1-(4-(3,4-dihydro-2-oxoquinolin-1(2H)-yl)piperidin-1-yl)-2-(2-(2-fluoroethoxy)-4-((1-(methylsulfonyl)piperidin-4-yl)oxy)phenyl)ethanone 
• 1369358-01-9 1-(1-(2-(2-methoxy-4-((1-(methylsulfonyl)piperidin-4-yl)oxy)phenyl)acetyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one 

Relevant articles and documents

Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors

Compounds 1-4 were synthesized and investigated for selectivity and potency for the oxytocin receptor (OTR) to determine their viability as radioactive ligands. Binding assays determined 1-4 to have high binding affinity for both the human and rodent OTR

Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency

Structure-activity studies on the oxytocin antagonist 1 (L-371,257; K(i) = 9.3 nM) have led to the identification of a related series of compounds containing an ortho-trifluoroethoxyphenylacetyl core which are orally bioavailable and have significantly improved potency in vitro and in vivo, e.g., compound 8 (L-374,943; K(i) = 1.4 nM).